https://doi.org/10.22037/jcma.v1i1.10604

Management of Alveolar Proteinosis by Bronchopulmonary lavage under Extra Corporeal Membrane Oxygenation (ECMO)

authors:

avatar Tahereh Parsa 1 , avatar Ardeshir Tajbakhsh ORCID 2 , avatar Zargham Hossein Ahmadi ORCID 3 , avatar Behrooz Farzanegan 1 , avatar Alireza Jahangirifard ORCID 2 , *

Tracheal Disease Research Center,National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran,Iran
Journal of Cellular & Molecular Anesthesia: Vol.1, issue 1; e150241
published online: December 23, 2015
article type: Brief Communications

How To Cite Parsa T, Tajbakhsh A, Hossein Ahmadi Z, Farzanegan B, Jahangirifard A. Management of Alveolar Proteinosis by Bronchopulmonary lavage under Extra Corporeal Membrane Oxygenation (ECMO). J Cell Mol Anesth. 2016;1(1):e150241. https://doi.org/10.22037/jcma.v1i1.10604.

Abstract

The gold standard of treating Pulmonary Alveolar Proteinosis (PAP) is bronchopulmonary lavage (BPL). We describe a rare case of BPD for PAP, who underwent extracorporeal membrane oxygenation (ECMO) due to hypoventilation in the setting of one-lung ventilation. First, the clinical course of the patient is presented; furthermore, the biomolecular basis of PAP and new treatment approaches is discussed. ?

References

  • 1.

    References are in the PDF file of the article.